Involved field (IF) radiotherapy is as effective as extended field (EF) radiotherapy after 2 cycles of COPP/ABVD in patients (pts) with intermediate-stage Hodgkin's disease (HD): A randomized multicenter study.

被引：0
|
作者：
Engert, A [1 ]
Schiller, P [1 ]
Pfistner, B [1 ]
Herrmann, R [1 ]
Koch, P [1 ]
Bossevin, F [1 ]
Schaber, R [1 ]
Loeffler, M [1 ]
Duehmke, F [1 ]
Mueller-Hermelink, HK [1 ]
Paulus, U [1 ]
Rueffer, JU [1 ]
Sieber, M [1 ]
Wolf, J [1 ]
Diehl, V [1 ]
机构：
[1] Univ Cologne, German Hodgkins Study Grp, Med Ctr, Cologne, Germany
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3199
引用
收藏
页码：768A / 768A
页数：1
相关论文
共 50 条
  • [1] Intermediate stage Hodgkin's disease:: Preliminary results on 210 patients treated with four ABVD chemotherapy cycles plus extended versus involved field radiotherapy
    Anselmo, AP
    Cavalieri, E
    Osti, FM
    Cantonetti, M
    De Sanctis, V
    Alfo, M
    Amadori, S
    Enrici, RM
    ANTICANCER RESEARCH, 2004, 24 (06) : 4045 - 4050
  • [2] Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: Final results of the German Hodgkin's Lymphoma Study Group trial HD5
    Sieber, M
    Tesch, H
    Pfistner, B
    Rueffer, U
    Lathan, B
    Brosteanu, O
    Paulus, U
    Koch, T
    Pfreundschuh, M
    Loeffler, M
    Engert, A
    Josting, A
    Wolf, J
    Hasenclever, D
    Franklin, J
    Duehmke, E
    Georgii, A
    Schalk, KP
    Kirchner, H
    Doelken, G
    Munker, R
    Koch, P
    Herrmann, R
    Greil, R
    Anselmo, AP
    Diehl, V
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (02) : 476 - 484
  • [3] Two cycles ABVD plus extended field radiotherapy is superior to radiotherapy alone in early stage Hodgkin's disease: Results of the German Hodgkin's Lymphoma Study Group (GHSG) trial HD7.
    Sieber, M
    Franklin, J
    Tesch, H
    Rueffer, U
    Brillant, C
    Reineke, T
    Herrmann, R
    Boissevain, F
    Franke, A
    Pfreundschuh, M
    Hossfeld, DK
    Wingbermuehle, K
    Josting, A
    Wolf, J
    Paulus, U
    Mueller, RP
    Duehmke, E
    Engert, A
    Diehl, V
    BLOOD, 2002, 100 (11) : 93A - 93A
  • [4] ABVD and involved field radiotherapy for Hodgkin's disease (HD) in children: Experience at the INEN Lima-Peru
    Perez, C
    Wachtel, A
    Marcial, J
    PEDIATRIC RESEARCH, 2003, 53 (04) : 289A - 289A
  • [5] Three cycles of ABDV plus extended field radiotherapy in patients with poor prognosis early-intermediate stage Hodgkin's disease
    Lorusso, V
    Timurian, A
    Brandi, M
    Pellecchia, A
    Cramarossa, A
    Marzullo, F
    deLena, M
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (04) : 669 - 674
  • [6] Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma:: Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
    Engert, A
    Schiller, P
    Josting, A
    Herrmann, R
    Koch, P
    Sieber, M
    Boissevain, F
    de Wit, M
    Mezger, J
    Dühmke, E
    Willich, N
    Müller, RP
    Schmidt, BF
    Renner, H
    Müller-Hermelink, HK
    Pfistner, B
    Wolf, J
    Hasenclever, D
    Löffler, M
    Diehl, V
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (19) : 3601 - 3608
  • [7] Comparison of 30 Gy versus 20 Gy involved field radiotherapy after two versus four cycles ABVD in early stage Hodgkin's lymphoma
    Eich, HT
    Müller, RP
    Engert, A
    Wolf, J
    Hansemann, K
    Pfistner, B
    Diehl, V
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 56 - 56
  • [8] 12 weeks of chemotherapy (stanford V) and involved field radiotherapy (RT) are highly effective for bulky and advanced stage Hodgkin's disease (HD): A limited institution ecog pilot study.
    Horning, SJ
    Bennett, JM
    Bartlett, NL
    Williams, J
    Neuberg, D
    Cassileth, PA
    BLOOD, 1996, 88 (10) : 2681 - 2681
  • [9] Comparison of 30 Gy versus 20 Gy involved field radiotherapy after two versus four cycles ABVD in early stage Hodgkin's disease:: interim results of the German Hodgkin's Lymphoma Study Group (GHSG) trial hd10
    Müller, RP
    Eich, HT
    Wolf, J
    Pfistner, B
    Engert, A
    Diehl, V
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S205 - S205
  • [10] From extended field to involved field radiotherapy of early stage Hodgkin's disease [Von der extended-field- zur involved-field-radiotherapie des morbus Hodgkin in frühen stadien]
    Staar S.
    Müller R.P.
    Der Onkologe, 2000, 6 (12): : 1160 - 1168
12345